CEACAM6 is a prognostic biomarker and potential therapeutic target for gastric carcinoma.
Ru GQ, Han Y, Wang W, Chen Y, Wang HJ, Xu WJ, Ma J, Ye M, Chen X, He XL, Győrffy B, Zhao ZS, Huang D.
Ru GQ, et al. Among authors: zhao zs.
Oncotarget. 2017 Jul 20;8(48):83673-83683. doi: 10.18632/oncotarget.19415. eCollection 2017 Oct 13.
Oncotarget. 2017.
PMID: 29137373
Free PMC article.